Lipidemia Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Lipidemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting
Not Applicable

Penn Medicine Healthy Heart

HypertensionHyperlipidemias
University of Pennsylvania1,980 enrolled1 locationNCT06062394
Recruiting
Not Applicable

Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

Dyslipidemia Associated With Type II Diabetes Mellitus
Sin Gon Kim2,186 enrolled2 locationsNCT07359105
Recruiting
Phase 3

A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

Type 2 Diabetes (T2DM)LipidemiaMetabolic Syndrome (MetS)
NewAmsterdam Pharma300 enrolled20 locationsNCT07219602
Recruiting
Not Applicable

PILI 'Āina Household

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii210 enrolled2 locationsNCT06526273
Recruiting

Imaging the Pathogenesis of Cerebral Small Vessel Disease

HypertensionDiabetesHyperlipidemias+1 more
Johns Hopkins University50 enrolled1 locationNCT05703386
Recruiting
Not Applicable

'Ai Pono Cooking Demonstrations

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii1,780 enrolled2 locationsNCT06526650
Recruiting
Not Applicable

Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

ObesityHypertensionOverweight+4 more
Universidad Católica San Antonio de Murcia220 enrolled1 locationNCT07447362
Recruiting
Not Applicable

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

HypertensionHyperuricemiaHyperglycemia+2 more
China National Center for Cardiovascular Diseases100 enrolled1 locationNCT07400549
Recruiting
Not Applicable

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Congestive Heart FailureDepressionHypertension+10 more
University of Tennessee388 enrolled2 locationsNCT06374277
Recruiting
Not Applicable

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

Diabetes MellitusObesityHypertension+2 more
University of Connecticut72 enrolled3 locationsNCT07238556
Recruiting
Not Applicable

FELLAShip to Better Health

Obesity, OverweightHigh Blood GlucoseHigh Cholesterol+3 more
University of Alabama at Birmingham90 enrolled1 locationNCT07220213
Recruiting
Phase 3

Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting
Not Applicable

Inspire HER: Inspiring the Heart and Emotions for Radical Health

ObesityCardiovascular DiseasesHypertension+5 more
University of Alabama at Birmingham90 enrolled1 locationNCT06966258
Recruiting

Taining Golden Lake Comprehensive Chronic Disease Management Initiative

SarcopeniaDiabetes MellitusHypertension+4 more
First Affiliated Hospital of Fujian Medical University20,000 enrolled1 locationNCT07308314
Recruiting
Phase 2

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting
Not Applicable

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

Diabetes MellitusHypertensionHyperlipidemia+2 more
China National Center for Cardiovascular Diseases536 enrolled1 locationNCT06615609
Recruiting
Phase 3

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Dyslipidemia Associated With Type II Diabetes Mellitus
EMS228 enrolled1 locationNCT04602754
Recruiting

Military Health and Nutrition Examination Study

Cardiovascular DiseasesHypertensionType 2 Diabetes+1 more
Pennington Biomedical Research Center650 enrolled3 locationsNCT06380322
Recruiting
Not Applicable

Social Needs Screening and Chronic Diseases Study (WE CARE)

DepressionHypertensionDiabetes+2 more
University of Massachusetts, Worcester68,000 enrolled3 locationsNCT06903897
Recruiting

Gut Microbiota in Metabolic Surgery

Cardiovascular DiseasesHypertensionType 2 Diabetes+3 more
Vanderbilt University Medical Center300 enrolled1 locationNCT05000996